UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 353

Sortiert nach

Review article: current treatment options and management of functional dyspepsia

Alimentary pharmacology & therapeutics, 2012-07, Vol.36 (1), p.3-15

2012

Volltextzugriff (PDF)

Review article: the clinical pharmacology of proton pump inhibitors

Alimentary pharmacology & therapeutics, 2006-06, Vol.23 (s2), p.2-8

2006

Volltextzugriff (PDF)

Impact of persistent, frequent regurgitation on quality of life in heartburn responders treated with acid suppression: a multinational primary care study

Alimentary pharmacology & therapeutics, 2013-05, Vol.37 (10), p.1005-1010

2013

Volltextzugriff (PDF)

Systematic review and meta‐analysis: enhanced efficacy of proton‐pump inhibitor therapy for peptic ulcer bleeding in Asia – a post hoc analysis from the Cochrane Collaboration

Alimentary pharmacology & therapeutics, 2005-05, Vol.21 (9), p.1055-1061

2005

Volltextzugriff (PDF)

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding

Health technology assessment (Winchester, England), 2007-12, Vol.11 (51), p.iii

2007

Volltextzugriff (PDF)

Clinical trial: dexlansoprazole MR, a proton pump inhibitor with dual delayed‐release technology, effectively controls symptoms and prevents relapse in patients with healed erosive oesophagitis

Alimentary pharmacology & therapeutics, 2009-04, Vol.29 (7), p.742-754

2009

Volltextzugriff (PDF)

Systematic review and meta‐analysis: proton‐pump inhibitor treatment for ulcer bleeding reduces transfusion requirements and hospital stay – results from the Cochrane Collaboration

Alimentary pharmacology & therapeutics, 2005-08, Vol.22 (3), p.169-174

2005

Volltextzugriff (PDF)

Clinical trial: efficacy and safety of dexlansoprazole MR 60 and 90 mg in healed erosive oesophagitis – maintenance of healing and symptom relief

Alimentary pharmacology & therapeutics, 2009-11, Vol.30 (9), p.895-907

2009

Volltextzugriff (PDF)

Review article: immediate‐release proton‐pump inhibitor therapy – potential advantages

Alimentary pharmacology & therapeutics, 2005-12, Vol.22 (s3), p.25-30

HOWDEN, C. W.

2005

Volltextzugriff (PDF)

Adherence to best practice guidelines in dyspepsia: a survey comparing dyspepsia experts, community gastroenterologists and primary‐care providers

Alimentary pharmacology & therapeutics, 2009-04, Vol.29 (8), p.871-881

2009

Volltextzugriff (PDF)

Changing perceptions and practices regarding aspirin, nonsteroidal anti‐inflammatory drugs, and cyclooxygenase‐2 selective nonsteroidal anti‐inflammatory drugs among US primary care providers

Alimentary pharmacology & therapeutics, 2008-11, Vol.28 (10), p.1249-1258

2008

Volltextzugriff (PDF)

Proton pump inhibitor treatment for acute peptic ulcer bleeding

Cochrane database of systematic reviews, 2006-01 (1), p.CD002094

2006

Volltextzugriff (PDF)

Commentary: improving the use of gastroprotective agents among high‐risk NSAID users

Alimentary pharmacology & therapeutics, 2013-05, Vol.37 (10), p.1019-1019

Howden, C. W.

2013

Volltextzugriff (PDF)

Commentary: PPIs and risk of serious infection in decompensated cirrhosis

Alimentary pharmacology & therapeutics, 2012-12, Vol.36 (11-12), p.1094-1094

Howden, C. W.

2012

Volltextzugriff (PDF)

Meta‐analysis: the efficacy of intravenous H2‐receptor antagonists in bleeding peptic ulcer

Alimentary pharmacology & therapeutics, 2002-06, Vol.16 (6), p.1137-1142

2002

Volltextzugriff (PDF)

Commentary: the link between community-acquired pneumonia and PPI use

Alimentary pharmacology & therapeutics, 2012-12, Vol.36 (11-12), p.1101-1101

Howden, C. W.

2012

Volltextzugriff (PDF)

Commentary: something new to consider in the treatment of Helicobacter pylori infection?

Alimentary pharmacology & therapeutics, 2012-08, Vol.36 (4), p.399-399

Howden, C. W.

2012

Volltextzugriff (PDF)

Dose–response evaluation of the antisecretory effect of continuous infusion intravenous lansoprazole regimens over 48 h

Alimentary pharmacology & therapeutics, 2006-04, Vol.23 (7), p.975-984

2006

Volltextzugriff (PDF)

Metaanalysis of randomized controlled trials of endoscopic retrograde cholangiography and endoscopic sphincterotomy for the treatment of acute biliary pancreatitis

The American journal of gastroenterology, 1999-11, Vol.94 (11), p.3211-3214

1999

Volltextzugriff (PDF)

Letter: possible association between PPI use and spontaneous bacterial peritonitis

Alimentary pharmacology & therapeutics, 2015-09, Vol.42 (6), p.778-779

2015

Volltextzugriff (PDF)

Meta‐analysis of randomized controlled trials comparing standard clinical doses of omeprazole and lansoprazole in erosive oesophagitis

Alimentary pharmacology & therapeutics, 2001-02, Vol.15 (2), p.227-231

2001

Volltextzugriff (PDF)

Prospective, randomized, controlled comparison of the use of polyethylene glycol electrolyte lavage solution in four-liter versus two-liter volumes and pretreatment with either magnesium citrate or bisacodyl for colonoscopy preparation

Gastrointestinal endoscopy, 1998-02, Vol.47 (2), p.167-171

1998

Volltextzugriff (PDF)

Systematic review: is there excessive use of proton pump inhibitors in gastro‐oesophageal reflux disease?

Alimentary pharmacology & therapeutics, 2004-12, Vol.20 (11‐12), p.1241-1251

2004

Volltextzugriff (PDF)

Primary care physician perceptions of non‐steroidal anti‐inflammatory drug and aspirin‐associated toxicity: results of a national survey

Alimentary pharmacology & therapeutics, 2006-03, Vol.23 (5), p.655-668

2006

Volltextzugriff (PDF)

Programme of stepping down from twice daily proton pump inhibitor therapy for symptomatic gastro‐oesophageal reflux disease associated with a formulary change at a VA medical center

Alimentary pharmacology & therapeutics, 2007-03, Vol.25 (6), p.709-714

2007

Volltextzugriff (PDF)

1 – 25 von 353

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(315)
Mit Volltextzugriff
(252)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(233)
Humans
(214)
Life Sciences & Biomedicine
(210)
Gastroenterology & Hepatology
(120)
Biological And Medical Sciences
(111)
Medical Sciences
(106)
Male
(89)
Adult
(67)
Female
(65)
Middle Aged
(63)
Pharmacology. Drug Treatments
(57)
Pharmacology & Pharmacy
(54)
Digestive System
(49)
Aged
(42)
Proton Pump Inhibitors
(36)
Gastroenterology. Liver. Pancreas. Abdomen
(34)
Gastroenterology
(30)
Helicobacter Pylori
(27)
Anti-Ulcer Agents - Therapeutic Use
(26)
General & Internal Medicine
(24)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Review article: current treatment options and management of functional dyspepsia

Review article: the clinical pharmacology of proton pump inhibitors

Impact of persistent, frequent regurgitation on quality of life in heartburn responders treated with acid suppression: a multinational primary care study

Systematic review and meta‐analysis: enhanced efficacy of proton‐pump inhibitor therapy for peptic ulcer bleeding in Asia – a post hoc analysis from the Cochrane Collaboration

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding

Clinical trial: dexlansoprazole MR, a proton pump inhibitor with dual delayed‐release technology, effectively controls symptoms and prevents relapse in patients with healed erosive oesophagitis

Systematic review and meta‐analysis: proton‐pump inhibitor treatment for ulcer bleeding reduces transfusion requirements and hospital stay – results from the Cochrane Collaboration

Clinical trial: efficacy and safety of dexlansoprazole MR 60 and 90 mg in healed erosive oesophagitis – maintenance of healing and symptom relief

Review article: immediate‐release proton‐pump inhibitor therapy – potential advantages

Adherence to best practice guidelines in dyspepsia: a survey comparing dyspepsia experts, community gastroenterologists and primary‐care providers

Changing perceptions and practices regarding aspirin, nonsteroidal anti‐inflammatory drugs, and cyclooxygenase‐2 selective nonsteroidal anti‐inflammatory drugs among US primary care providers

Proton pump inhibitor treatment for acute peptic ulcer bleeding

Commentary: improving the use of gastroprotective agents among high‐risk NSAID users

Commentary: PPIs and risk of serious infection in decompensated cirrhosis

Meta‐analysis: the efficacy of intravenous H2‐receptor antagonists in bleeding peptic ulcer

Commentary: the link between community-acquired pneumonia and PPI use

Commentary: something new to consider in the treatment of Helicobacter pylori infection?

Dose–response evaluation of the antisecretory effect of continuous infusion intravenous lansoprazole regimens over 48 h

Metaanalysis of randomized controlled trials of endoscopic retrograde cholangiography and endoscopic sphincterotomy for the treatment of acute biliary pancreatitis

Letter: possible association between PPI use and spontaneous bacterial peritonitis

Meta‐analysis of randomized controlled trials comparing standard clinical doses of omeprazole and lansoprazole in erosive oesophagitis

Prospective, randomized, controlled comparison of the use of polyethylene glycol electrolyte lavage solution in four-liter versus two-liter volumes and pretreatment with either magnesium citrate or bisacodyl for colonoscopy preparation

Systematic review: is there excessive use of proton pump inhibitors in gastro‐oesophageal reflux disease?

Primary care physician perceptions of non‐steroidal anti‐inflammatory drug and aspirin‐associated toxicity: results of a national survey

Programme of stepping down from twice daily proton pump inhibitor therapy for symptomatic gastro‐oesophageal reflux disease associated with a formulary change at a VA medical center

Suchergebnisse filtern